Dave Muoio

By Dave Muoio 11:54 amJanuary 8, 2020
Online fitness membership platform ClassPass announced this morning the close of a hefty $285 million Series E investment round that, according to a spokesperson, propels the New York-based company’s valuation past the $1 billion mark. The new raise was led by L Catterton and Apax Digital, while prior backer Temasek also made an appearance. As a result of their participation, L Catterton’s Marc...
By Dave Muoio 04:05 pmJanuary 7, 2020
Editor's note: This story has been updated with additional statements from Pear Therapeutics. Pear Therapeutics pulled back the curtain this morning on a number of new deals between the prescription digital therapeutics maker and other tech companies or researchers. Ranging from virtual reality therapies to voice biomarker tech, the moves appear to be an effort from Pear to add new products to...
By Dave Muoio 11:45 amJanuary 7, 2020
Stockholm, Sweden-based telemedicine platform KRY (known as LIVI outside of the Nordics) has announced a €140 million ($155 million) Series C funding round led by Ontario Teachers’ Pension Plan’s Teachers’ Innovation Platform. Existing investors Index Ventures, Creandum and Accel also participated. WHAT THEY DO KRY is Sweden’s first digital medicine platform, being founded in 2014 and launched in...
By Dave Muoio 07:00 amJanuary 7, 2020
Non-emergency medical transportation (NEMT) coordination platform Ride Health has closed a $6.2 million seed funding round, it announced this morning. Activate Venture Partners headed the raise, with additional participation from New York Ventures, Newark Venture Partners, BioAdvance and Startup Health. WHAT THEY DO Ride Health offers a real-time, web and mobile NEMT platform for health plan and...
By Dave Muoio 08:57 amJanuary 6, 2020
Repisodic, maker of a software platform that streamlines hospital discharge decision-making, has raised $1.75 million in a seed funding round led by American Enterprise Group. WHAT THEY DO Repisodic patient-facing, HIPAA-compliant tool looks to simplify discharge from care. Rather than having case managers or social workers present patients with packets or pamphlets, the software runs users...
By Dave Muoio 02:57 pmJanuary 2, 2020
On Apple and patents. A New York University School of Medicine cardiologist is unhappy with Apple Watch’s heart rate irregularity detection feature, which he claims in a new lawsuit infringes his own patent for atrial fibrillation detection technology. Filed in the US District Court for the Eastern District of New York on December 27, 2019, the suit describes Dr. Joseph Wiesel’s invention and his...
By Dave Muoio 08:53 amDecember 27, 2019
Much like its predecessors, 2019 was yet another year in which Apple furthered its push into the healthcare market. Although headlined as always by the health tracking features of its consumer wearables, the company has also embraced a number of other projects that align its interests with long-time industry players and — in the words of its healthcare leaders — empower and democratize health for...
By Dave Muoio 02:55 pmDecember 19, 2019
Gympass, a platform for employer’s benefits programs that offers fitness class bookings to members, announced this week the acquisition of Lisbon, Portugal-based artificial intelligence company Flaner. With this, the Brazil-grown fitness platform will be opening up a new “Tech Hub” in Lisbon that will begin with Flaner’s current employees and expand to a full staff of 50, according to Gympass....
By Dave Muoio 01:40 pmDecember 19, 2019
ECG algorithm picks up Breakthrough Device status. Eko, the maker of tools for monitoring heart function, announced yesterday that a novel ECG-based algorithm for detecting lowered left ventricular ejection fraction has received Breakthrough Device designation from the FDA. By analyzing a 15-second clip of ECG data collected via the company’s other products, the algorithm aims to assist with...
By Dave Muoio 03:28 pmDecember 18, 2019
OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures. WHAT THEY DO OM1’s cloud platform employs AI machine learning organize and analyze large datasets for real-world measures of clinical...